While coronavirus spent the majority of 2020 wreaking havoc on earth, pharmaceutical companies have been busy at work trying to invent a vaccine to combat it. Several companies, such as Pfizer, Moderna and AstraZeneca, have competed neck and neck to be the first to deliver a cure to the world. Renowned pharmaceutical companies have been successful in developing the vaccine, which will be protected under the Trade-Related Aspects of Intellectual Property Rights Agreement (TRIPS).
Recent Posts
- Other Barks & Bites for Friday, March 7: Lashify Wins ITC Appeal on Economic Prong Analysis; CAFC Says Apple Did Not Violate Discovery Obligations at PTAB; and ParkerVision Files Reply Brief on Rule 36 Appeal at SCOTUS
- Rio Tinto is Seeking an IP Counsel Innovation & Technology
- Moderna COVID Vaccine Technology Struck Down by PTAB
- IPWatchdog LIVE 2025 Panel Explores Global IP Trends
- Supreme Court Denies Cert on Section 101, Fraudulent Procurement of Trademark Petitions